Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.4 | 0.7 |
| Revenue growth | -100.0% | -98.5% | -43.0% | |
| Cost of goods sold | 0.5 | 1.0 | 0.6 | 0.5 |
| Gross profit | -0.5 | -1.0 | -0.3 | 0.2 |
| Gross margin | | -16483.3% | -66.8% | 28.0% |
| Selling, general and administrative | 49.2 | 262.1 | 38.3 | 7.2 |
| Research and development | 78.2 | 252.4 | 29.6 | 7.0 |
| EBIT | -137.5 | -515.5 | -68.1 | -14.0 |
| EBIT margin | | -8591600.0% | -17551.0% | -2059.5% |
| Pre-tax income | -105.7 | -504.0 | -67.7 | -12.2 |
| Income taxes | 1.7 | 1.3 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% |
| Net income | -107.4 | -505.3 | -67.7 | -12.2 |
| Net margin | | -8422166.7% | -17451.8% | -1790.7% |
| |
| Diluted EPS | ($0.37) | ($2.14) | ($0.43) | ($0.10) |
| Shares outstanding (diluted) | 293.5 | 235.6 | 155.9 | 126.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|